S0003692

ATV/r 300mg+100mg tabs/PAC-30


Atazanavir 300mg+Ritonavir 100mg heat stable tablets in bottle packs of 30
Indicative Price : Upon Request

NOTE: The description below is for a standard product. It is not specific to patent status and pricing policies that may apply at country level. This information is available on request from Supply Division: Contact: supply@unicef.org

General Description:
Atazanavir 300mg +Ritonavir 100mg tablets, bottle pack of 30

Technical Specifications:
Each film coated tablet contains a fixed boosted protease inhibitor combination of Atazanavir 100mg + Ritonavir 100mg in a heat stable formulation.

Therapeutic class:
Protease Inhibitor (boosted)

Standard shelf life:
2 years (24 months)

Other available formulations:
None

Guidelines for use:
For more details, please click the links listed below:

WHO treatment guidelines

and

WHO Essential Medicines Library

or your regional national guidelines

Indications:
Management of HIV-1 infection of adults in combination with at least two other antiretroviral medicines. By mouth (oral), PO.

Storage:
Do not store above 30ºC. Keep in original airtight container. Excursions permitted to 15-30ºC (59-86ºF). Protect from Moisture.
Keep out of reach and sight of children.

Dispensing instructions:
Dispense in original container. Do not repack.
Tablets should be swallowed whole and not chewed, broken or crushed.
To be taken with food.
Warning: Formulation contains lactose

Regulatory Status:
For latest updates, please click the links listed below:

List of WHO Prequalified Medicines

List of USFDA approved and tentatively approved items


Important information regarding supply for this product

Please click on the link:
http://www.unicef.org/supply/index_81996.html
Related Products